ClinicalTrials.govpublic full text
Prevention of Heart Failure Induced by Doxorubicin With Early Administration of Dexrazoxane
degradation of top2b and top2a in human by dexrazoxane, time course and degradation of top2b in human by dexrazoxane, effects of dexrazoxane on healthy human, dexrazoxane, topoisomerase 2b, human, doxorubicin cardio-toxicity, cardio-oncology, onco-cardiology, prevention of cardio-toxicity by doxorubicin, early administration of dexrazoxane, interventional
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 1030130
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.